Nguyen et al. reported that a relatively high dose (10 μM) of DAC promoted Nrf2 activation via mitochondrial ROS (mitoROS) induction, triggering DAC resistance in AML cells [36]. The gene discussed is NFE2L2; the disease is acute myeloid leukemia.